0000000000431947

AUTHOR

M D’onghia

showing 2 related works from this author

Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP).

2013

Multiple Sclerosis Natalizumab TySTOPSettore MED/26 - Neurologia
researchProduct

TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP

2014

Multiple scleorsinatalizumabSettore MED/26 - Neurologia
researchProduct